UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology and surveillance for hepatocellular carcinoma: New trends

Journal of hepatology, 2020-02, Vol.72 (2), p.250-261

2020

Volltextzugriff (PDF)

Optimal management of hepatitis B virus infection – EASL Special Conference

Journal of hepatology, 2015-11, Vol.63 (5), p.1238-1253

2015

Volltextzugriff (PDF)

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

Journal of hepatology, 2010-08, Vol.53 (2), p.348-356

2010

Volltextzugriff (PDF)

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies

Viruses, 2022-10, Vol.14 (11), p.2404

2022

Volltextzugriff (PDF)

IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection

The Journal of immunology (1950), 2012-10, Vol.189 (8), p.3925-3935

2012

Volltextzugriff (PDF)

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Liver international, 2020-08, Vol.40 (8), p.1841-1852

2020

Volltextzugriff (PDF)

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

Journal of hepatology, 2019-05, Vol.70 (5), p.1008-1015

2019

Volltextzugriff (PDF)

The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia

Liver international, 2022-01, Vol.42 (1), p.16-25

2022

Volltextzugriff (PDF)

The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analogue therapy

Journal of hepatology, 2021-08, Vol.75 (2), p.474-480

2021

Volltextzugriff (PDF)

Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy

The American journal of gastroenterology, 2021-06, Vol.116 (6), p.1342-1344

2021

Volltextzugriff (PDF)

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)

PloS one, 2021-04, Vol.16 (4), p.e0249614-e0249614

2021

Volltextzugriff (PDF)

S1932 Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 96 Interim Analysis of a Phase 3 Randomized Study

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S1384-S1385

2024

Volltextzugriff (PDF)

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine

Hepatology (Baltimore, Md.), 2005-12, Vol.42 (6), p.1414-1419

2005

Volltextzugriff (PDF)

Non-invasive assessment of liver fibrosis in chronic hepatitis B

World journal of gastroenterology : WJG, 2014-10, Vol.20 (40), p.14568-14580

2014

Volltextzugriff (PDF)

Correction: Micheli et al. Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. Nutrients 2020, 12 , 1819

Nutrients, 2024-07, Vol.16 (13), p.2130

2024

Volltextzugriff (PDF)

Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians

Palliative medicine, 2024-10, Vol.38 (9), p.1033-1041

2024

Volltextzugriff (PDF)

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

Hepatology communications, 2020-01, Vol.4 (1), p.5-7

2020

Volltextzugriff (PDF)

S1617 Elevations in Total Serum Bile Acids During Bulevirtide Treatment Show No Association With Adverse Events of Interest in Patients With Chronic Hepatitis Delta: An Integrated Safety Analysis of 48-Week Data

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1214-S1214

2023

Volltextzugriff (PDF)

Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C

Journal of hepatology, 2011-04, Vol.54 (4), p.621-628

2011

Volltextzugriff (PDF)

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

Journal of rheumatology, 2016-05, Vol.43 (5), p.869-874

2016

Volltextzugriff (PDF)

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

The Journal of experimental medicine, 2007-03, Vol.204 (3), p.667-680

2007

Volltextzugriff (PDF)

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease

Gut, 2021-09, Vol.70 (9), p.1782-1794

2021

Volltextzugriff (PDF)

S1179 Bulevirtide Monotherapy at Low and High Dose in Patients With Chronic Hepatitis Delta: 24-Week Interim Data of the Phase 3 MYR301 Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e858-e859

2022

Volltextzugriff (PDF)

1 – 25 von 561

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(542)
Mit Volltextzugriff
(500)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(296)
Life Sciences & Biomedicine
(292)
Gastroenterology & Hepatology
(202)
Humans
(190)
Male
(105)
Female
(102)
Middle Aged
(96)
Hepatitis B
(93)
Antiviral Agents - Therapeutic Use
(89)
Hepatitis
(85)
Adult
(78)
Cirrhosis
(77)
Patients
(69)
Hepatitis B, Chronic - Drug Therapy
(62)
Liver Cirrhosis
(62)
Hepatitis B Virus
(59)
Aged
(57)
Hepatocellular Carcinoma
(56)
Liver Diseases
(50)
Treatment Outcome
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(234)
Hepatology
(34)
Liver International
(34)
Gut
(22)
Gastroenterology
(17)
Digestive And Liver Disease
(14)
Alimentary Pharmacology & Therapeutics
(11)
Journal Of Viral Hepatitis
(8)
The American Journal Of Gastroenterology
(8)
Jhep Reports
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Epidemiology and surveillance for hepatocellular carcinoma: New trends

Optimal management of hepatitis B virus infection – EASL Special Conference

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies

IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia

The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analogue therapy

Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)

S1932 Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 96 Interim Analysis of a Phase 3 Randomized Study

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine

Non-invasive assessment of liver fibrosis in chronic hepatitis B

Correction: Micheli et al. Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. Nutrients 2020, 12 , 1819

Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

S1617 Elevations in Total Serum Bile Acids During Bulevirtide Treatment Show No Association With Adverse Events of Interest in Patients With Chronic Hepatitis Delta: An Integrated Safety Analysis of 48-Week Data

Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease

S1179 Bulevirtide Monotherapy at Low and High Dose in Patients With Chronic Hepatitis Delta: 24-Week Interim Data of the Phase 3 MYR301 Study

Suchergebnisse filtern